| pubmed-article:11762347 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11762347 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:11762347 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:11762347 | lifeskim:mentions | umls-concept:C0334227 | lld:lifeskim |
| pubmed-article:11762347 | lifeskim:mentions | umls-concept:C0068624 | lld:lifeskim |
| pubmed-article:11762347 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:11762347 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
| pubmed-article:11762347 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
| pubmed-article:11762347 | pubmed:dateCreated | 2001-12-12 | lld:pubmed |
| pubmed-article:11762347 | pubmed:abstractText | Neuroendocrine molecules are now believed to play a significant role in the progression of human prostate cancer (CaP), especially in the androgen-independent stage. | lld:pubmed |
| pubmed-article:11762347 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11762347 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11762347 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11762347 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11762347 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11762347 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11762347 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11762347 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11762347 | pubmed:issn | 0923-7534 | lld:pubmed |
| pubmed-article:11762347 | pubmed:author | pubmed-author:MottaMM | lld:pubmed |
| pubmed-article:11762347 | pubmed:author | pubmed-author:MagniPP | lld:pubmed |
| pubmed-article:11762347 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11762347 | pubmed:volume | 12 Suppl 2 | lld:pubmed |
| pubmed-article:11762347 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11762347 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11762347 | pubmed:pagination | S27-9 | lld:pubmed |
| pubmed-article:11762347 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11762347 | pubmed:meshHeading | pubmed-meshheading:11762347... | lld:pubmed |
| pubmed-article:11762347 | pubmed:meshHeading | pubmed-meshheading:11762347... | lld:pubmed |
| pubmed-article:11762347 | pubmed:meshHeading | pubmed-meshheading:11762347... | lld:pubmed |
| pubmed-article:11762347 | pubmed:meshHeading | pubmed-meshheading:11762347... | lld:pubmed |
| pubmed-article:11762347 | pubmed:meshHeading | pubmed-meshheading:11762347... | lld:pubmed |
| pubmed-article:11762347 | pubmed:meshHeading | pubmed-meshheading:11762347... | lld:pubmed |
| pubmed-article:11762347 | pubmed:meshHeading | pubmed-meshheading:11762347... | lld:pubmed |
| pubmed-article:11762347 | pubmed:meshHeading | pubmed-meshheading:11762347... | lld:pubmed |
| pubmed-article:11762347 | pubmed:meshHeading | pubmed-meshheading:11762347... | lld:pubmed |
| pubmed-article:11762347 | pubmed:meshHeading | pubmed-meshheading:11762347... | lld:pubmed |
| pubmed-article:11762347 | pubmed:meshHeading | pubmed-meshheading:11762347... | lld:pubmed |
| pubmed-article:11762347 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11762347 | pubmed:articleTitle | Expression of neuropeptide Y receptors in human prostate cancer cells. | lld:pubmed |
| pubmed-article:11762347 | pubmed:affiliation | Center for Endocrinologial Oncology Institute of Endocrinology University of Milan, Italy. paolo.magni@unimi.it | lld:pubmed |
| pubmed-article:11762347 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11762347 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11762347 | lld:pubmed |
